Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Adeno-Associated Virus-based Gene Therapy for Hemophilia A and B: A Systematic Review and Meta-Analysis

Saarang R. Deshpande, Keerthy Deena Joseph, Jiayi Tong, Yong Chen, Allyson Pishko, Adam Cuker

Blood Adv bloodadvances.2024014111.

https://doi.org/10.1182/bloodadvances.2024014111

Published: 2024

Includes: Supplemental data

Journal Articles

ASH Guideline Oversight Subcommittee Response to Jacobs et al regarding Industry Payments to ASH Guideline Panelists

Menaka Pai, Michael Byrne, Adam Cuker, Benjamin Djulbegovic, Jim George, Matthew Seftel, Deirdra R. Terrell, Robert Kunkle, Matthew C. Cheung

Blood Adv (2024) 8 (13): 3553–3554.

https://doi.org/10.1182/bloodadvances.2024013293

Published: 2024

Includes: Supplemental data

Journal Articles

Distinguishing ASH clinical practice guidelines from other forms of ASH clinical advice

Adam Cuker, Robert Kunkle, Rachel S. Bercovitz, Michael Byrne, Benjamin Djulbegovic, Sandra L. Haberichter, Jennifer Holter-Chakrabarty, Richard Lottenberg, Menaka Pai, Suely M. Rezende, Matthew D. Seftel, Roy L. Silverstein, Deirdra R. Terrell, Matthew C. Cheung

Blood Adv (2024) 8 (11): 2960–2963.

https://doi.org/10.1182/bloodadvances.2023011102

Published: 2024

Journal Articles

Cost-effectiveness of rapid vs in-house vs send-out ADAMTS13 testing for immune thrombotic thrombocytopenic purpura

Cecily Allen, Satoko Ito, Ayesha Butt, Adriana Purcell, Rhys Richmond, Christopher A. Tormey, Harlan M. Krumholz, Adam Cuker, George Goshua

Blood Adv (2024) 8 (9): 2279–2289.

https://doi.org/10.1182/bloodadvances.2024012608

Published: 2024

Includes: Supplemental data

Journal Articles

Effectiveness and safety of prophylactic anticoagulation among hospitalized patients with inflammatory bowel disease

Ghadeer K. Dawwas, Adam Cuker, Douglas E. Schaubel, James D. Lewis

Blood Adv (2024) 8 (5): 1272–1280.

https://doi.org/10.1182/bloodadvances.2023011756

Published: 2024

Includes: Supplemental data

Journal Articles

ASH Clinical Practice Guidelines: strategies to stay up-to-date

Matthew C. Cheung, Rob Kunkle, Rob Plovnick, Richard Lottenberg, Suely M. Rezende, Roy Silverstein, Menaka Pai, Matthew Seftel, Adam Cuker

Blood Adv (2023) 7 (21): 6707–6709.

https://doi.org/10.1182/bloodadvances.2023011481

Published: 2023

Journal Articles

Identifying experts for clinical practice guidelines: perspectives from the ASH Guideline Oversight Subcommittee

Michael Byrne, Ryan Mattison, Rachel Bercovitz, Richard Lottenberg, Suely M. Rezende, Roy Silverstein, Deirdra Terrell, Rob Kunkle, Deion Smith, Catherine Bollard, Sandra Haberichter, Jennifer Holter-Chakrabarty, Menaka Pai, Matthew Cheung, Adam Cuker, Matthew Seftel, Benjamin Djulbegovic

Blood Adv (2023) 7 (16): 4323–4326.

https://doi.org/10.1182/bloodadvances.2023010039

Published: 2023

Journal Articles

Influence of participant and reviewer characteristics in application scores for a hematology research training program

Sara K. Vesely, Allison King, Emily Vettese, John G. Heller, Adam Cuker, Cecelia Calhoun, Wendy Stock, Morgan Homer, Josel Fritz, Lillian Sung

Blood Adv (2023) 7 (15): 4064–4071.

https://doi.org/10.1182/bloodadvances.2023009792

Published: 2023

Includes: Supplemental data

Journal Articles

Adding caplacizumab to standard of care in thrombotic thrombocytopenic purpura: a systematic review and meta-analysis

Mia Djulbegovic, Jiayi Tong, Alice Xu, Joanna Yang, Yong Chen, Adam Cuker, Allyson M. Pishko

Blood Adv (2023) 7 (10): 2132–2142.

https://doi.org/10.1182/bloodadvances.2022008443

Published: 2023

Includes: Supplemental data

Journal Articles

American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients

Blood Adv (2022) 6 (17): 4975–4982.

https://doi.org/10.1182/bloodadvances.2022007940

Published: 2022

Includes: Supplemental data

Journal Articles

American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients

Blood Adv (2022) 6 (17): 4915–4923.

https://doi.org/10.1182/bloodadvances.2022007561

Published: 2022

Includes: Supplemental data

Journal Articles

American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis

Adam Cuker, Eric K. Tseng, Robby Nieuwlaat, Pantep Angchaisuksiri, Clifton Blair, Kathryn Dane, Jennifer Davila, Maria T. DeSancho, David Diuguid, Daniel O. Griffin, Susan R. Kahn, Frederikus A. Klok, Alfred Ian Lee, Ignacio Neumann, Ashok Pai, Marc Righini, Kristen M. Sanfilippo, Deborah Siegal, Mike Skara, Deirdra R. Terrell, Kamshad Touri, Elie A. Akl, Reyad Nayif Al Jabiri, Yazan Nayif Al Jabiri, Angela M. Barbara, Antonio Bognanni, Imad Bou Akl, Mary Boulos, Romina Brignardello-Petersen, Rana Charide, Matthew Chan, Luis E. Colunga-Lozano, Karin Dearness, Andrea J. Darzi, Heba Hussein, Samer G. Karam, Philipp Kolb, Razan Mansour, Gian Paolo Morgano, Rami Z. Morsi, Giovanna Muti-Schünemann, Menatalla K. Nadim, Atefeh Noori, Binu A. Philip, Thomas Piggott, Yuan Qiu, Yetiani Roldan Benitez, Finn Schünemann, Adrienne Stevens, Karla Solo, Wojtek Wiercioch, Reem A. Mustafa, Holger J. Schünemann

Blood Adv (2022) 6 (2): 664–671.

https://doi.org/10.1182/bloodadvances.2021005945

Published: 2022

Includes: Supplemental data

Journal Articles

How to write a guideline: a proposal for a manuscript template that supports the creation of trustworthy guidelines

Blood Adv (2021) 5 (22): 4721–4726.

https://doi.org/10.1182/bloodadvances.2020003577

Published: 2021

Includes: Supplemental data

Journal Articles

American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients

Blood Adv (2021) 5 (20): 3951–3959.

https://doi.org/10.1182/bloodadvances.2021005493

Published: 2021

Includes: Supplemental data

Journal Articles

Self-reported positive impact of mentored clinical research training is associated with academic success in hematology

Allison A. King, Sara K. Vesely, Grace Dadzie, Cecelia Calhoun, Adam Cuker, Wendy Stock, Alison Walker, Josel Fritz, Lillian Sung

Blood Adv (2021) 5 (14): 2919–2924.

https://doi.org/10.1182/bloodadvances.2021004421

Published: 2021

Includes: Supplemental data

Journal Articles

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

Blood Adv (2021) 5 (3): 872–888.

https://doi.org/10.1182/bloodadvances.2020003763

Published: 2021

Includes: Supplemental data

Journal Articles

Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses

Rebecca L. Morgan, Vahid Ashoorion, Adam Cuker, Housne Begum, Stephanie Ross, Nina Martinez, Beng H. Chong, Lori A. Linkins, Theodore E. Warkentin, Wojtek Wiercioch, Robby Nieuwlaat, Holger Schünemann, Nancy Santesso

Blood Adv (2020) 4 (20): 5184–5193.

https://doi.org/10.1182/bloodadvances.2020002963

Published: 2020

Includes: Supplemental data

Journal Articles

American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism

Blood Adv (2020) 4 (19): 4693–4738.

https://doi.org/10.1182/bloodadvances.2020001830

Published: 2020

Includes: Supplemental data

Journal Articles

Soluble glycoprotein VI is a predictor of major bleeding in patients with suspected heparin-induced thrombocytopenia

Allyson M. Pishko, Robert K. Andrews, Elizabeth E. Gardiner, Daniel S. Lefler, Adam Cuker

Blood Adv (2020) 4 (18): 4327–4332.

https://doi.org/10.1182/bloodadvances.2020002861

Published: 2020

Includes: Supplemental data

Journal Articles

Pharmacometric modeling to explore 4F-PCC dosing strategies for VKA reversal in patients with INR below 2

Ravi Sarode, Katsuyuki Fukutake, Masahiro Yasaka, Michael A. Tortorici, Antoinette Mangione, Marc Pfister, Adam Cuker

Blood Adv (2020) 4 (17): 4208–4216.

https://doi.org/10.1182/bloodadvances.2020002267

Published: 2020

Includes: Supplemental data

NARROW

Adeno-Associated Virus-based Gene Therapy for Hemophilia A and B: A Systematic Review and Meta-Analysis

ASH Guideline Oversight Subcommittee Response to Jacobs et al regarding Industry Payments to ASH Guideline Panelists

Distinguishing ASH clinical practice guidelines from other forms of ASH clinical advice

Cost-effectiveness of rapid vs in-house vs send-out ADAMTS13 testing for immune thrombotic thrombocytopenic purpura

Effectiveness and safety of prophylactic anticoagulation among hospitalized patients with inflammatory bowel disease

ASH Clinical Practice Guidelines: strategies to stay up-to-date

Identifying experts for clinical practice guidelines: perspectives from the ASH Guideline Oversight Subcommittee

Influence of participant and reviewer characteristics in application scores for a hematology research training program

Adding caplacizumab to standard of care in thrombotic thrombocytopenic purpura: a systematic review and meta-analysis

American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients

American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients

American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis

How to write a guideline: a proposal for a manuscript template that supports the creation of trustworthy guidelines

American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients

Self-reported positive impact of mentored clinical research training is associated with academic success in hematology

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses

American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism

Soluble glycoprotein VI is a predictor of major bleeding in patients with suspected heparin-induced thrombocytopenia

Pharmacometric modeling to explore 4F-PCC dosing strategies for VKA reversal in patients with INR below 2

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only